ClinicalTrials.govpublic full text
Reduced Antithrombotic Strategy for High Bleeding Risk Patients With Myocardial Infarction
myocardial infarction, high bleeding risk, cyp2c19 genotyping, dual antiplatelet therapy, percutaneous coronary intervention, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1010326
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.